Clinical Trials List
Protocol Number110WHA0110091
2021-08-01 - 2023-05-31
Others
Recruiting1
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 黃文盛 Division of Nuclear Medicine
- 陳世彬 Division of Neurology
- 陳韋達 Division of Neurology
- 陳世彬 Division of Neurology
- Shuu-Jiun Wang Division of Neurology
- YEN-FENG WANG Division of Neurology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30-60 participants
-
Global
30-60 participants
